Abstract
Binding to receptors in the cell nucleus is crucial for the action of lipophilic hormones and ligands. PPAR-γ (for peroxisome proliferator-activated receptor) is a nuclear hormone receptor that mediates adipocyte differentiation1,2 and modulates insulin sensitivity3, cell proliferation4 and inflammatory processes5,6. PPAR-γ ligands have been implicated in the development of atherogenic foam cells7 and as potential cancer treatments8. Transcriptional activity of PPAR-γ is induced by binding diverse ligands, including natural fatty acid derivatives9,10,11, antidiabetic thiazolidinediones12, and non-steroidal anti-inflammatory drugs13. Ligand binding by PPAR-γ, as well as by the entire nuclear-receptor superfamily, is an independent property of the carboxy-terminal ligand-binding domain (LBD) of the receptor14,15. Here we show that ligand binding by PPAR-γ is regulated by intramolecular communication between its amino-terminal A/B domain and its carboxy-terminal LBD. Modification of the A/B domain, for example by physiological phosphorylation by MAP kinase, reduces ligand-binding affinity, thus negatively regulating the transcriptional and biological functions of PPAR-γ. The ability of the A/B domain to regulate ligand binding has important implications for the evaluation and mechanism of action of potentially therapeutic ligands that bind PPAR-γ and that are likely to extend to other members of the nuclear-receptor superfamily.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tontonoz, P., Hu, E. & Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79, 1147–1159 (1994).
Shao, D. & Lazar, M. A. PPARγ, C/EBPα, cell cycle status and the commitment to adipocyte differentiation. J. Biol. Chem. 272, 21473–21478 (1997).
Willson, T. M. et al. The structure–activity relationship between peroxisome proliferator-activated receptor γ and the antihyperglycemic activity of thiazolidinediones. J. Med. Chem. 39, 665–668 (1996).
Altiok, S., Xu, M. & Spiegelman, B. M. PPARγ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev. 11, 1987–1998 (1997).
Jiang, C., Tring, A. T. & Seed, B. PPAR-γ agonists inhibit productions of monocyte inflammatory cytokines. Nature 391, 82–86 (1998).
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J. & Glass, C. K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79–82 (1998).
Nagy, L., Tontonoz, P., Alvarez, J. G., Chen, H. & Evans, R. M. Oxidized LDL regulates macrophage gene expression through activation of PPARγ. Cell 93, 229–240 (1998).
Tontonoz, P. et al. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor. Proc. Natl Acad. Sci. USA 94, 237–241 (1997).
Yu, K. et al. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270, 23975–23983 (1995).
Kliewer, S. A. et al. Aprostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83, 813–819 (1995).
Forman, B. M. et al. 15-deoxy, delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803–812 (1995).
Lehman, J. M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for the nuclear peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270, 12953–12956 (1995).
Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M. & Kliewer, S. A. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272, 3406–3410 (1997).
Mangelsdorf, D. J. et al. The nuclear receptor superfamily: the second decade. Cell 83, 835–839 (1995).
Wurtz, J. M. et al. Acanonical structure for the ligand binding domain of nuclear receptors. Nature Struct. Biol. 3, 87–94 (1996).
Camp, H. S. & Tafuri, S. R. Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase. J. Biol. Chem. 272, 13452–13457 (1997).
Adams, M., Reginato, M. J., Shao, D., Lazar, M. A. & Chatterjee, V. K. Transcriptional activation by PPARγ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272, 5128–5132 (1997).
Hu, E., Kim, J. B., Sarraf, P. & Spiegelman, B. M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274, 2100–2103 (1992).
Allan, G. F. et al. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J. Biol. Chem. 267, 19513–19520 (1992).
Berger, J. et al. Thiazolidinediones produce a conformational change in peroxisome proliferator-activated receptor-γ: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137, 4189–4195 (1996).
Lavinsky, R. M. et al. Diverse signalling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl Acad. Sci. USA 95, 2920–2925 (1998).
Refetoff, S., Weiss, R. E. & Usala, S. J. The syndromes of resistance to thyroid hormone. Endocrine Rev. 14, 348–399 (1993).
Reginato, M. J., Krakow, S. L., Bailey, S. T. & Lazar, M. A. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor γ. J. Biol. Chem. 273, 1855–1858 (1998).
McBroom, L. D. B., Flock, G. & Giguere, V. The nonconserved hinge region and distinct amino-terminal domains of the RORα orphan nuclear receptor isoforms are required for proper DNA bending and RORα-DNA interactions. Mol. Cell. Biol. 15, 796–808 (1995).
Tzagarakis-Foster, C. & Privalsky, M. L. Phosphorylation of thyroid hormone receptors by protein kinase A regulates DNA recognition by specific inhibition of receptor monomer binding. J. Biol. Chem. 273, 10926–10932 (1998).
Bunone, G., Briand, P. A., Miksicek, R. J. & Picard, D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15, 2174–2183 (1996).
Kato, S. et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270, 1491–1494 (1995).
McInerney, E. M., Tsai, M. J., O'Malley, B. W. & Katzenellenbogen, B. S. Analysis of estrogen receptor transcriptional enhancement by steroid hormone receptor coactivator. Proc. Natl Acad. Sci. USA 93, 10069–10073 (1996).
Schwarz, E. J., Reginato, M. J., Shao, D., Krakow, S. L. & Lazar, M. A. Retinoic acid blocks adipogenesis by inhibiting C/EBPβ-mediated transcription. Mol. Cell. Biol. 17, 1552–1561 (1997).
Krey, G. et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11, 779–791 (1997).
Acknowledgements
This work was supported by grants from the National Institute of Diabetes, Digestive, and Kidney Disease at the NIH.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shao, D., Rangwala, S., Bailey, S. et al. Interdomain communication regulating ligand binding by PPAR-γ. Nature 396, 377–380 (1998). https://doi.org/10.1038/24634
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/24634
This article is cited by
-
LMO3 reprograms visceral adipocyte metabolism during obesity
Journal of Molecular Medicine (2021)
-
PPARγ and Diabetes: Beyond the Genome and Towards Personalized Medicine
Current Diabetes Reports (2021)
-
Triphenyl phosphate is a selective PPARγ modulator that does not induce brite adipogenesis in vitro and in vivo
Archives of Toxicology (2020)
-
Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα
Nature Communications (2017)
-
Bamboo (Phyllostachys bambusoides) leaf extracts inhibit adipogenesis by regulating adipogenic transcription factors and enzymes in 3T3-L1 adipocytes
Food Science and Biotechnology (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.